Nemonoxacin
ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: taigexyn, TG 873870, TG-873870
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Nemonoxacin is a drug catalogued in DrugCentral. Recorded indications include Community acquired pneumonia.
- Indications: Community acquired pneumonia.
- ATC code: J01MB08 (Other quinolones).
- Molecular formula: C20H25N3O4; molecular weight 371.44 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Community acquired pneumonia
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01MB08 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › QUINOLONE ANTIBACTERIALS › Other quinolones |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Nemonoxacin is on its molecule page.
| Molecular formula | C20H25N3O4 |
|---|---|
| Molecular weight | 371.44 g/mol |
| CAS number | 378746-64-6 |
| InChIKey | AVPQPGFLVZTJOR-RYUDHWBXSA-N |
| PubChem CID | 11993740 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Nemonoxacin used for?
DrugCentral lists the following indications for Nemonoxacin: Community acquired pneumonia.
What is the chemical formula of Nemonoxacin?
Nemonoxacin has the molecular formula C20H25N3O4 and a molecular weight of 371.44 g/mol.
Browse: all drugs starting with N · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5079 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1213456 — compound record and bioactivity
- PubChem CID 11993740 — chemical identifiers
- DrugBank DB06600 — drug record
- FDA UNII P94L0PVO94 — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.